Skip to main content
Book cover

The Duration and Safety of Osteoporosis Treatment

Anabolic and Antiresorptive Therapy

  • Book
  • © 2016

Overview

  • Focuses on the duration and safety of anabolic and antiresorptive drug therapies for osteoporosis

  • Examines common and serious side effects of extended drug treatment, especially bisphosphonates

  • Discusses diagnosis and management of osteonecrosis of the jaw and atypical femur fractures

This is a preview of subscription content, log in via an institution to check access.

Access this book

eBook USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Other ways to access

Licence this eBook for your library

Institutional subscriptions

Table of contents (23 chapters)

Keywords

About this book

Providing a comprehensive review of short-and long-term adverse events of both antiresorptive and anabolic drugs, this practical guide updates the clinician on the pathophysiology of osteoporosis and the principles behind our present and future pharmaceuticals. Leading practitioners in the field examine all current literature and data regarding the duration and safety of these therapies, with recommendations for clinicians on decision-making and best practices for osteoporosis patients. An overview of the pathophysiology and epidemiology of osteoporosis and discussion of both anabolic and antiresorptive drugs is followed by fracture risk assessment and an examination of treatment failures. Next, a number of chapters are dedicated to the diagnosis, presentation and management of atypical femur fractures and osteonecrosis of the jaw (ONJ), each of which are significant patient concerns when using these osteoporosis treatments. The introduction and utilization of drug holidays is also discussed, as well as the long-term outlook for management of osteoporotic patients. Written and edited by experts in the field, The Duration and Safety of Osteoporosis Treatment is a balanced resource for researchers, practitioners and policy-makers alike for clinical decision-making and patient care. 

Editors and Affiliations

  • Division of Rheumatology, Department of Medicine, Cedars-Sinai Medical Center; University of California Los Angeles, David Geffen School of Medicine, Los Angeles, USA

    Stuart Silverman

  • Institute of Clinical Research; Department of Medicine, Holbæk, Denmark, University of Southern Denmark, Odense Patient Data Explorative Network; Holbæk Hospital, Odense, Denmark

    Bo Abrahamsen

About the editors

Stuart L. Silverman, MD, FACP, FACR

Cedars-Sinai Medical Center

Division of Rheumatology

Department of Medicine

Los Angeles, CA, USA

University of California Los Angeles

David Geffen School of Medicine

Los Angeles, CA, USA

Bo Abrahamsen, MD, PhD

University of Southern Denmark

Odense Patient Data Explorative Network

Institute of Clinical Research

Odense, Denmark

Holbæk Hospital

Department of Medicine
Holbæk, Denmark

Bibliographic Information

  • Book Title: The Duration and Safety of Osteoporosis Treatment

  • Book Subtitle: Anabolic and Antiresorptive Therapy

  • Editors: Stuart Silverman, Bo Abrahamsen

  • DOI: https://doi.org/10.1007/978-3-319-23639-1

  • Publisher: Springer Cham

  • eBook Packages: Medicine, Medicine (R0)

  • Copyright Information: Springer International Publishing Switzerland 2016

  • Softcover ISBN: 978-3-319-23638-4Published: 08 January 2016

  • eBook ISBN: 978-3-319-23639-1Published: 29 December 2015

  • Edition Number: 1

  • Number of Pages: XVI, 338

  • Number of Illustrations: 62 b/w illustrations, 38 illustrations in colour

  • Topics: Endocrinology, Orthopedics

Publish with us